granted
on 29 Apr 2024
Last Applicant/ Owned by
6005 Hidden Valley Road
Carlsbad
CA
92011
Serial Number
90263391 filed on 19th Oct 2020
Registration Number
N/A
Correspondent Address
Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
pharmaceutical research and products development for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; research and development of therapeutics for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulaRead More
pharmaceutical research and products development for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; research and development of therapeutics for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; research and development in the field of small molecule therapeutics; scientific research for medical purposes in the field of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; medical and scientific research in the field of pharmaceuticals, all of the foregoing related to therapies that target nucleic acids and modulate gene expression
11th 000101
11th 000101
pharmaceutical preparations for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; therapeutic pharmaceuticals for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; small molecule therapies for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation, all of the foregoing related to therapies that target nucleic acids and modulate gene expression
11th 000101
11th 000101
No 90263391
No Service Mark
No 56009-TM1001
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 30th Apr 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 29th Apr 2024 | SOU TEAS EXTENSION RECEIVED |
| 29th Apr 2024 | SOU EXTENSION 2 GRANTED |
| 29th Apr 2024 | SOU EXTENSION 2 FILED |
| 24th Oct 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 20th Oct 2023 | SOU EXTENSION 1 FILED |
| 20th Oct 2023 | SOU EXTENSION 1 GRANTED |
| 20th Oct 2023 | SOU TEAS EXTENSION RECEIVED |
| 21st Jul 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 21st Jul 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
